Home
Molecular Imaging Center (MIC)

Main content

  1. Arnesen V, Erikstein BS, Mukherjee H, Sulen A, Popa M, Sørnes S, Reikvam H, Chan KP, Hovland R, McCormack E, Bruserud Ø, Myers AG, Gjertsen BT. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis 2016 Dec 1;7(12):e2497. Doi: 10.1038(cddis.2016.392.
  2. Baumann A, Jorge-Finnigan A, Jung-Kc K, Sauter A, Horvath I, Morozova-Roche LA, Martinez A. Tyrosine hydroxylase binding to phospholipid membranes prompts its amyloid aggregation and compromises bilayer integrity. Sci Rep Dec 22;6:39488. Doi: 10.1038/srep39488.
  3. Bittins M, Wang X. TNT-induced phagocytosis: Tunneling nanotubes mediate the transfer of pro-phagocytic signals from apoptotic to viable cells. J Cell Physiol 2016 Sep 3. Doi: 10.102/jcp.25584.
  4. Bougnaud S, Golebiewska A, Oudin A, Keunen O, Harter PN, Mäder L, Azuaje F, Fritah S, Stieber D, Kaoma T, Vallar L, Brons NHC, Daubon T, Miletic H, Sundstrøm T, herold-Mende C, Mittelbronn M, Bjerkvig R, Niclou S. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget May 31;7(22):31955-71.
  5. Dominguez-Valentin M, Gras Navarro A, Rahman AM, Kumar S, Reti`ere C, Ulvestad E, Kristensen V, Lund-Johansen M, Lie BA, Enger PØ, Njølstad G, Kristoffersen E, Lie SA, Chekenya M. Identification of a natural killer cell receptor allele that prolongs survival of cytomegalovirus-positive glioblastoma patients. Cancer Res 2016 Sep 15;76(18):5326-36.
  6. Eskilsson E, Røsland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt TJirik R, Fritah S, Harter P, Välk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Leiss L, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PØ, Winkler F, Ritter CA, Niclou S, Watts C, Bjerkvig R, Miletic R. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro Oncol 2016;18(12):1644-1655.
  7. Grindheim AK, Hollås H, Raddum AM, Saraste J, Vedeler A. reactive oxygen species exert opposite effects on Tyr23 phophorylation of the nuclear and cortical pools of annexin A2. J Cell Sci 2016 Jan;129(2):314-28.
  8. Helland Ø, Popa M, Bischof K, Gjertsen BT, McCormack E, Bjørge L. The HDACi Panobinostat shows growth inhibition in vitro and in a bioluminescent orthotopic surgical xenograft model of ovarian cancer. PLoS One 2016 Jun 28;11(6):e0158208.
  9. Kuipers SD, Trentani A, Tiron A, Mao X, Kuhl D, Bramham CR. BDNF-induced LTP is associated with rapid Arc/Arg3.1-dependent enhancement in adult hippocampal neurogenesis. Sci Rep 2016 Feb 18;6:21222.
  10. Leitch C, Osdal T, Andresen V, Molland M, Kristiansen S, Nguyen XN, Bruserud Ø, Gjertsen BT, McCormack E. Hydroxyurea synergizes with valrpoic acid in wild-type p53 acute myeloid leukemia. Ocotarget 2016 feb 16;7(7):8105-18.
  11. Mamaeva V, Niemi R, Beck M, Özliseli E, Desai D, Landor S, Gronroos T, Kronqvist P, Pettersen IK, McCormack E, Rosenholm JM, Linden M, Sahlgren C. Inhibiting Notch activity in breast cancer stem cells by glucose functionalised nanoparticles carrying g-secretase inhibitors. Mol Ther 2016 Dec 26. doi: 10.1038/mt.2016.42.
  12. Netland IA, Førde HE, Sleire L, Leiss L, Rahman MA, Skeie BS, Gjerde CH, Enger PØ, Goplen D. Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. BMC Cancer 2016 Aug 19;16:657. Doi: 10.1186/s12885-016-2712-4.
  13. Netland IA, Førde HE, Sleire L, Leiss L, Rahman MA, Skeie BS, Miletic H, Enger PØ, Goplen D. Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. J Neurooncol 2016 Aug;129(1):57-66.
  14. Qu Y, Gharbi N, Yuan X, Olsen JR, Blicher P, Dalhus B, Brokstad KA, Lin B, Øyan AM, Zhang W, Kalland KH, Ke X. Axitinib blocks Wnt/b-catenin signaling and directs asymmetric cell division in cancer. Proc Natl Acad Sci U S A 2016 Aug 16;113(33):9339-44.
  15. Reigstad I, Smeland HY, Skogstrand T, Sortland K, Schmid MC, Reed RK, Stuhr L. Stromal inytegrin a11b1 affects RM11 prostate and 4T1 breast xenograft tumors differently. PLoS One 2016 Mar 18;11(3):e0151663.
  16. Reigstad I, Sortland RK, Skogstrand T, Reed RK, Stuhr L. The effect of stromal integrin b3-deficiency on two different tumors in mice. Cancers 2016 Jan 12;8(1). doi: 10.3390/cancers8010014.
  17. Sand K, Theorell J, Bruserud Ø, Bryceson YT, Kittang AO. Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes. Cancer Immunol Immunother 2016 Sep;65(9):1135-47.
  18. Schoelermann J, Burtey A, Allouni ZE, Gerdes HH, Cimpan MR. Contact-dependent transfer of TIO2 nanoparticles between mammalian cells. Nanotoxicology 2016 Mar;10(2):204-15.
  19. Suliman S, Mustafa K, Krueger A, Steinmüller-Nethl D, Finne-Wistrand A, Osdal T, Hamza AO, Sun Y, Parajuli H, Waag T, Nickel J, Johannessen AC, McCormack E, Costea DE. Nanodiamond modified copolymer scaffolds affects tumour progression of early neoplastic oral keratinocytes. Biomaterials 2016 Jul;95:11-21.
  20. Talasila KM, Røsland GV, Hagland HR, Eskilsson E, Flønes IH, Fritah S, Azuaje F, Atai N, Harter PN, Mittelbronn M, Andersen M, Joseph JV, Hossain JA, Vallar L, Noorden CJ, Niclou SP, Thorsen F, Tronstad KJ, Tzoulis C, Bjerkvig R, Miletic H. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro Oncol 2016 Sep 3. Pii:now175.
  21. Van Damme P, Kalvik TV, Starheim KK, Jonckheere V, Gevaert K, Arnesen T. A role for human n-alpha acetyltransferase 30 (Naa30) in maintaining mitochondrial integrity.  Mol Cell Proteomics 2016 Nov; 15(11):3361-3372.